Pseudohyperphosphatemia associated with high-dose liposomal amphotericin B therapy

Clinica Chimica Acta

Volumn 387, Issue 1-2, 2008, Pages 145-149

  Lane, Jason W ^a   Rehak, Nadja N ^a   Hortin, Glen L ^a   Zaoutis, Theoklis ^b,c   Krause, Philip R ^d   Walsh, Thomas J ^e  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Liposomal amphotericin B (L AMB); Pseudohyperphosphatemia; Synchron LX20

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CREATININE; PHOSPHATE;

ADULT; ANALYZER; ARTICLE; CASE REPORT; CHRONIC GRANULOMATOUS DISEASE; CREATININE BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG MEGADOSE; FEMALE; FOLLOW UP; HUMAN; HYPERPHOSPHATEMIA; MUCORMYCOSIS; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PSEUDOHYPERPHOSPHATEMIA;

AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LIPOSOMES; MIDDLE AGED; PHOSPHATES;

EID: 35748943223     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.08.008     Document Type: Article

References (22)

1. Adler-Moore J., and Proffitt R.T. AmBisome: liposomal formulation, structure, mechanism of action, and pre-clinical experience. J Antimicrob Chemother 49 Suppl S1 (2002) 21-30
2. Leenders A.C., Daenen S., Jansen R.L., et al. Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia-associated invasive fungal infections. Br J Haematol 103 (1998) 205-212
3. Prentice H.G., Hann I.M., Herbrecht R., et al. A randomised comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. Br J Haematol 98 (1997) 711-718
4. Walsh T.J., Finberg R.W., Arndt C., et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. N Engl J Med 340 (1999) 764-771
5. Kontoyiannis D.P., Andersson B.S., Lewis R.E., and Raad I.I. Progressive disseminated aspergillosis in a bone marrow transplant recipient: response with a high-dose lipid formulation of amphotericin B. Clin Infect Dis 32 (2001) e94-e96
6. Barron M.A., Lay M., and Madinger N.E. Surgery and treatment with high-dose liposomal amphotericin B for eradication of craniofacial zygomycosis in a patient with Hodgkin's disease who had undergone allogeneic hematopoietic stem cell transplantation. J Clin Microbiol 43 (2005) 2012-2014
7. Crompton J.A., Alexander D., Somerville T., and Shihab F.S. Lipid-based amphotericin in pulmonary zygomycosis: safety and efficacy of high exposure in a renal allograft patient. Transpl Infect Dis 6 (2004) 183-187
8. Walsh T.J., Goodman J.L., Pappas P., et al. Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B in patients infected with Aspergillus species and other filamentous fungi: maximal tolerated dose study. Antimicrob Agents Chemother 45 (2001) 3487-3496
9. Jain A., and Butani L. Severe hyperphosphatemia resulting from high-dose liposomal amphotericin in a child with leukemia. J Pediatr Hematol Oncol 25 (2003) 324-326
10. Weisenger J.R. Bellorin-Font. Magnesium and phosphorus. Lancet 352 (1998) 391-396
11. Thatte L., Oster J.R., Singer I., Bourgoignie J.J., Fishman L.M., and Roos B.A. Review of the literature: severe hyperphosphatemia. Am J Med Sci 310 (1995) 167-174
12. Nir-Paz R., Cohen R., and Haviv Y.S. Acute hyperphosphatemia caused by sodium phosphate enema in a patient with liver dysfunction and chronic renal failure. Ren Fail 21 (1999) 541-544
13. Kirschbaum B. The acidosis of exogenous phosphate intoxication. Arch Intern Med 158 (1998) 405-408
14. Vukasin P., Weston L.A., and Beart R.W. Oral Fleet phospho-soda laxative induced hyperphosphatemia and hypocalcemic tetany in an adult: report of a case. Dis Colon Rectum 40 (1997) 1396-1397
15. Larner A.J. Pseudohyperphosphatemia. Clin Biochem 28 (1995) 391-393
16. Barutcuoglu B., Parildar Z., Mutaf I., Habif S., and Bayindar O. Spuriously elevated inorganic phosphate concentration in a multiple myeloma patient. Clin Lab Haematol 25 (2003) 271-274
17. Jamil M.G., Abdel-Raheem M.M., and Potti A. Pseudohyperphosphatemia associated with Waldenstrom's macroglobulinemia. Am J Hematol 65 (2000) 329
18. Randall A.G., Garcia-Webb P., and Beilby J.P. Interference by haemolysis, icterus, and lipaemia in assays on the Beckman Synchron CX5 and methods for correction. Ann Clin Biochem 27 (1990) 345-352
19. Adler S.G., Laidlaw S.A., Lubran M.M., and Kopple J.D. Hyperglobulinemia may spuriously elevate measured serum inorganic phosphate concentrations. Am J Kidney Dis 11 (1988) 260-263
20. Walsh T.J., Yeldandi V., McEvoy M., et al. Safety, tolerance, and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome) in neutropenic patients. Antimicrob Agents Chemother 42 (1998) 2391-2398
21. Heinemann V., Bosse D., Jehn U., et al. Pharmacokinetics of liposomal amphotericin B (AmBisome) in critically ill patients. Antimicrob Agents Chemother 41 (1997) 1275-1280
22. Bailey H.L., and Chan E.M. Liposomal Amphotericin B interferes with the phosphorus assay on the Synchron LX 20 analyzer. Clin Chem 53 (2007) 795-796